Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 47 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Alcon Laboratories Belgium from Puurs-Sint-Amands, company number BE0830069679, closed financial year 2025 with a result of € 4.4 million after tax. For that financial year Alcon Laboratories Belgium recorded revenue of € 169.7 million and equity of € 26.6 million. Compared with financial year 2024, the result moved from € 4 million to € 4.4 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.
€ 26.6 million
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4.4 million
▲ 10% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 26.5 million.
People and assets in 2025
401.8
▲ 16.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 38.9 million
▲ 8% vs 2024
€ 96,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 469,318
▼ 8% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 44.2 million
▲ 32% vs 2024
Loans from banks and other lenders, long and short.
€ 27.5 million
▲ 15% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 81 days on average.
€ 8.1 million
▼ 12% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 159,602,091 | € 171,594,882 | € 166,455,038 | € 169,723,029 | ▲ 2% |
| Profit after taxes | € 3,684,635 | € 4,309,619 | € 4,015,410 | € 4,407,729 | ▲ 10% |
| Equity | € 13,825,372 | € 18,134,990 | € 22,150,400 | € 26,558,129 | ▲ 20% |
| Total debts | € 57,151,305 | € 62,545,224 | € 66,913,516 | € 80,107,914 | ▲ 20% |
| Land & buildings | € 10,262,597 | € 9,936,693 | € 9,610,789 | € 9,284,885 | ▼ 3% |
| Retained profit | € 13,806,822 | € 18,116,440 | € 22,131,850 | € 26,539,579 | ▲ 20% |
| Bank debt | € 20,290,209 | € 26,062,100 | € 33,599,035 | € 44,188,228 | ▲ 32% |
| Balance sheet total | € 71,249,414 | € 80,938,604 | € 89,285,438 | € 107,172,566 | ▲ 20% |
| Employees (FTE) | 403.8 | 394.1 | 385 | 401.8 | ▲ 16.8 |
Key figures of Alcon Laboratories Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Alcon Laboratories Belgium?
What happened at Alcon Laboratories Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 4.4 million (▲ 10% vs 2024). Source: NBB ↗
- Jason Mangum became a director. NBB
- Gerald Patrick Collier stepped down as director. NBB
- Liesbeth Tack became a director. NBB
- Gerald Patrick Collier became a director. NBB
- Yannick Cools became a director. NBB
- New establishment in Bornem. KBO
- New establishment in Puurs-Sint-Amands. KBO
In short
From € 3.7 million profit in 2022 to € 4.4 million profit in 2025.
Paid € 6.9 million in corporate taxes since 2022.
Best year ever: 2025, with € 4.4 million profit.
Pays suppliers within 81 days on average.
A new publication or filing at Alcon Laboratories Belgium? We notify you, reason included.
Follow Alcon Laboratories BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Alcon Laboratories Belgium are Yannick Cools, Jason Mangum and Liesbeth Tack. The shares are held by Alcon Inc (99.9%) and Alcon Pharmaceuticals Limited (0.1%).
Directors
According to the 2025 annual accounts
Yannick Cools
Director
since 2021
Jason Mangum
Director
since 2025
Liesbeth Tack
Director
since 2024
Gerald Patrick Collier
Director
since 2022 · until 2025
Shareholders
Alcon Inc
99.9%
Alcon Pharmaceuticals Limited
0.1%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Lichterveld 3
2870 Puurs-Sint-Amands
Klein-Mechelen(BOR) 18G
2880 Bornem
Active since 1 November 2018
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
Domain
Domain
alcon.com
Registered
1998-12-27
Registrar
MarkMonitor Inc.
Expires
2026-12-21
Website info
Features
Security
Network
Details
- Company number
- 0830.069.679
- VAT number
- BE 0830.069.679
- Registered office
- Lichterveld 3, 2870 Puurs-Sint-Amands
- Names & denominations
- Alcon Laboratories Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 October 2010
- Peppol
- Active · Active since 21 Aug 2025
- Contact
- alcon.com
- Activities · NACE
Vervaardiging van geneesmiddelen
Overige zakelijke dienstverlening, neg
Vervaardiging van overige farmaceutische producten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Groothandel in farmaceutische en medische artikelen
Overige gespecialiseerde wetenschappelijke en technische activiteiten